These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

370 related items for PubMed ID: 28682499

  • 1. High-dose dexamethasone or all-trans-retinoic acid restores the balance of macrophages towards M2 in immune thrombocytopenia.
    Feng Q, Xu M, Yu YY, Hou Y, Mi X, Sun YX, Ma S, Zuo XY, Shao LL, Hou M, Zhang XH, Peng J.
    J Thromb Haemost; 2017 Sep; 15(9):1845-1858. PubMed ID: 28682499
    [Abstract] [Full Text] [Related]

  • 2. High-dose dexamethasone corrects impaired myeloid-derived suppressor cell function via Ets1 in immune thrombocytopenia.
    Hou Y, Feng Q, Xu M, Li GS, Liu XN, Sheng Z, Zhou H, Ma J, Wei Y, Sun YX, Yu YY, Qiu JH, Shao LL, Liu XG, Hou M, Peng J.
    Blood; 2016 Mar 24; 127(12):1587-97. PubMed ID: 26744458
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effects of high-dose dexamethasone on regulating interleukin-22 production and correcting Th1 and Th22 polarization in immune thrombocytopenia.
    Cao J, Chen C, Li L, Ling-yu Z, Zhen-yu L, Zhi-ling Y, Wei C, Hai C, Sang W, Kai-lin X.
    J Clin Immunol; 2012 Jun 24; 32(3):523-9. PubMed ID: 22289995
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of Eltrombopag on In Vitro Macrophage Polarization in Pediatric Immune Thrombocytopenia.
    Di Paola A, Palumbo G, Merli P, Argenziano M, Tortora C, Strocchio L, Roberti D, Santoro C, Perrotta S, Rossi F.
    Int J Mol Sci; 2020 Dec 24; 22(1):. PubMed ID: 33374151
    [Abstract] [Full Text] [Related]

  • 7. Distinct alterations of CD68+CD163+ M2-like macrophages and myeloid-derived suppressor cells in newly diagnosed primary immune thrombocytopenia with or without CR after high-dose dexamethasone treatment.
    Shao X, Wu B, Cheng L, Li F, Zhan Y, Liu C, Ji L, Min Z, Ke Y, Sun L, Chen H, Cheng Y.
    J Transl Med; 2018 Mar 02; 16(1):48. PubMed ID: 29499727
    [Abstract] [Full Text] [Related]

  • 8. Tumor Necrosis Factor-α Blockade Corrects Monocyte/Macrophage Imbalance in Primary Immune Thrombocytopenia.
    Zhao Y, Xu P, Guo L, Wang H, Min Y, Feng Q, Hou Y, Sun T, Li G, Ji X, Qiu J, Peng J, Liu X, Hou M.
    Thromb Haemost; 2021 Jun 02; 121(6):767-781. PubMed ID: 33469903
    [Abstract] [Full Text] [Related]

  • 9. Effects of rituximab and dexamethasone on regulatory and proinflammatory B-cell subsets in patients with primary immune thrombocytopenia.
    Gudbrandsdottir S, Brimnes M, Køllgaard T, Hasselbalch HC, Nielsen CH.
    Eur J Haematol; 2018 Jan 02; 100(1):45-52. PubMed ID: 28960473
    [Abstract] [Full Text] [Related]

  • 10. High-Dose Dexamethasone Alters the Increase in Interleukin-16 Level in Adult Immune Thrombocytopenia.
    Wang X, Li L, Wang Y, Li X, Feng Q, Hou Y, Ma C, Gao C, Hou M, Peng J.
    Front Immunol; 2019 Jan 02; 10():451. PubMed ID: 30936868
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Participation of B-cell-activating factor receptors in the pathogenesis of immune thrombocytopenia.
    Min YN, Wang CY, Li XX, Hou Y, Qiu JH, Ma J, Shao LL, Zhang X, Wang YW, Peng J, Hou M, Shi Y.
    J Thromb Haemost; 2016 Mar 02; 14(3):559-71. PubMed ID: 26749059
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. High-dose dexamethasone shifts the balance of stimulatory and inhibitory Fcgamma receptors on monocytes in patients with primary immune thrombocytopenia.
    Liu XG, Ma SH, Sun JZ, Ren J, Shi Y, Sun L, Dong XY, Qin P, Guo CS, Hou M, Peng J.
    Blood; 2011 Feb 10; 117(6):2061-9. PubMed ID: 21131591
    [Abstract] [Full Text] [Related]

  • 16. Low-dose decitabine promotes M2 macrophage polarization in patients with primary immune thrombocytopenia via enhancing KLF4 binding to PPARγ promoter.
    Shao X, Xu P, Ji L, Wu B, Zhan Y, Zhuang X, Ou Y, Hua F, Sun L, Li F, Wang X, Chen H, Cheng Y.
    Clin Transl Med; 2023 Jul 10; 13(7):e1344. PubMed ID: 37488670
    [Abstract] [Full Text] [Related]

  • 17. Regulatory T-lymphocyte subsets in children with chronic immune thrombocytopenia after high-dose of dexamethasone.
    Elsayh KI, Saad K, Osman NS, Mahmoud KH, Ahmad FA, Khalaf SM, Sayed NG, Zahran ZAM, Ghandour AMA, Elhoufey AA, Bedir T, Zahran A.
    Pediatr Res; 2022 Nov 10; 92(5):1432-1436. PubMed ID: 35173302
    [Abstract] [Full Text] [Related]

  • 18. Correction of abnormal T cell subsets by high-dose dexamethasone in patients with chronic idiopathic thrombocytopenic purpura.
    Li J, Wang Z, Hu S, Zhao X, Cao L.
    Immunol Lett; 2013 Nov 10; 154(1-2):42-8. PubMed ID: 23994430
    [Abstract] [Full Text] [Related]

  • 19. Pulsed high-dose dexamethasone improves interleukin 10 secretion by CD5+ B cells in patients with primary immune thrombocytopenia.
    Hua F, Ji L, Zhan Y, Li F, Zou S, Wang X, Song D, Min Z, Gao S, Wu Y, Chen H, Cheng Y.
    J Clin Immunol; 2012 Dec 10; 32(6):1233-42. PubMed ID: 22669326
    [Abstract] [Full Text] [Related]

  • 20. High-dose dexamethasone inhibits BAFF expression in patients with immune thrombocytopenia.
    Zhu XJ, Shi Y, Sun JZ, Shan NN, Peng J, Guo CS, Qin P, Hou M.
    J Clin Immunol; 2009 Sep 10; 29(5):603-10. PubMed ID: 19499314
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.